Abbott Declares 356th Consecutive Quarterly Dividend

             Abbott Declares 356th Consecutive Quarterly Dividend

PR Newswire

ABBOTT PARK, Ill., Dec. 14, 2012

ABBOTT PARK, Ill., Dec. 14, 2012 /PRNewswire/ -- The board of directors of
Abbott (NYSE: ABT) today declared its 356^th consecutive quarterly cash
dividend. The quarterly dividend is $0.14 per share, payable Feb. 15, 2013, to
shareholders of record on Jan. 15, 2013. The management of AbbVie, Abbott's
research-based pharmaceuticals business, intends to recommend a cash dividend,
subject to AbbVie board approval, of $0.40 per share, which together with
Abbott's dividend will equal a cash dividend of $0.54 per share, an increase
of nearly 6 percent over Abbott's quarterly cash dividend declared in
September 2012.

Abbott's annualized cash dividend of $0.56 per share, combined with AbbVie's
annualized cash dividend of $1.60 per share equals a total annualized cash
dividend of $2.16 per share, compared to the annualized cash dividend of
Abbott, prior to separation, of $2.04 per share. Future quarterly dividends,
including the expected AbbVie dividend in February 2013, are subject to
approval by each company's board of directors.

About Abbott
Abbott is a global, broad-based health care company devoted to the discovery,
development, manufacture and marketing of pharmaceuticals and medical
products, including nutritionals, devices and diagnostics. The company
employs approximately 91,000 people and markets its products in more than 130
countries.

Abbott's news releases and other information are available on the company's
Web site at www.abbott.com.

– Private Securities Litigation Reform Act of 1995 –

A Caution Concerning Forward-Looking Statements

Some statements in this news release may be forward-looking statements for
purposes of the Private Securities Litigation Reform Act of 1995. Abbott
cautions that these forward-looking statements are subject to risks and
uncertainties that may cause actual results to differ materially from those
indicated in the forward-looking statements. Economic, competitive,
governmental, technological and other factors that may affect Abbott's
operations are discussed in Item 1A, "Risk Factors," to our Annual Report on
Securities and Exchange Commission Form 10-K for the year ended Dec. 31, 2011
and in Item 1A, "Risk Factors," to our quarterly report on Securities and
Exchange Commission Form 10-Q for the quarter ended Sept. 30, 2012 and June
30, 2012, and are incorporated by reference. Abbott undertakes no obligation
to release publicly any revisions to forward-looking statements as a result of
subsequent events or developments, except as required by law.

SOURCE Abbott

Website: http://www.abbott.com
Contact: Media, Adelle Infante, +1-847-938-8745, or Financial, Larry Peepo,
+1-847-935-6722